Financhill
Sell
34

SND Quote, Financials, Valuation and Earnings

Last price:
$2.12
Seasonality move :
9.18%
Day range:
$2.10 - $2.16
52-week range:
$1.65 - $2.80
Dividend yield:
0%
P/E ratio:
52.50x
P/S ratio:
0.29x
P/B ratio:
0.37x
Volume:
139.5K
Avg. volume:
175.8K
1-year change:
13.03%
Market cap:
$91.2M
Revenue:
$296M
EPS (TTM):
-$0.14
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $233.1M $122.3M $126.6M $255.7M $296M
Revenue Growth (YoY) 9.7% -47.51% 3.52% 101.93% 15.73%
 
Cost of Revenues $152M $104.2M $142.6M $226.1M $254.4M
Gross Profit $81.1M $18.1M -$15.9M $29.6M $41.6M
Gross Profit Margin 34.78% 14.81% -12.56% 11.57% 14.04%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $22.9M $25.5M $25.5M $30.8M $38.7M
Other Inc / (Exp) -$12.7M $36.4M -$14.4M $1.1M -$1.3M
Operating Expenses $25.3M $27.4M $27.4M $33M $41.3M
Operating Income $55.8M -$9.3M -$43.3M -$3.4M $298K
 
Net Interest Expenses $3.6M $2.1M $2M $1.6M $1.3M
EBT. Incl. Unusual Items $39.4M $25M -$59.7M -$3.9M -$2.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $7.8M -$13M -$9M -$3.2M -$6.9M
Net Income to Company $31.6M $38M -$50.7M -$703K $4.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $31.6M $38M -$50.7M -$703K $4.6M
 
Basic EPS (Cont. Ops) $0.79 $0.94 -$1.21 -$0.02 $0.12
Diluted EPS (Cont. Ops) $0.78 $0.94 -$1.21 -$0.02 $0.12
Weighted Average Basic Share $40.1M $40.3M $41.8M $42.4M $38.9M
Weighted Average Diluted Share $40.3M $40.3M $41.8M $42.4M $39M
 
EBITDA $70.9M $50M -$31.6M $25M $27.3M
EBIT $43.1M $27.1M -$57.7M -$2.3M -$980K
 
Revenue (Reported) $233.1M $122.3M $126.6M $255.7M $296M
Operating Income (Reported) $55.8M -$9.3M -$43.3M -$3.4M $298K
Operating Income (Adjusted) $43.1M $27.1M -$57.7M -$2.3M -$980K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $23.4M $34.5M $71.6M $76.9M $63.2M
Revenue Growth (YoY) -64.36% 47.29% 107.64% 7.41% -17.87%
 
Cost of Revenues $18.2M $36.5M $60.2M $62.5M $56.7M
Gross Profit $5.2M -$2M $11.4M $14.4M $6.5M
Gross Profit Margin 22.14% -5.94% 15.96% 18.72% 10.27%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $6M $6.4M $7.6M $8.9M $9.7M
Other Inc / (Exp) $40M $1.8M $614K $290K -$1M
Operating Expenses $6.4M $6.7M $8.1M $9.6M $10.3M
Operating Income -$1.2M -$8.8M $3.3M $4.8M -$3.8M
 
Net Interest Expenses $497K $467K $411K $276K $344K
EBT. Incl. Unusual Items $38.2M -$7.4M $3.5M $4.8M -$5.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.9M -$169K $831K -$1.9M -$5.1M
Net Income to Company $36.3M -$7.3M $2.7M $6.7M -$98K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $36.3M -$7.3M $2.7M $6.7M -$98K
 
Basic EPS (Cont. Ops) $0.91 -$0.17 $0.06 $0.18 -$0.00
Diluted EPS (Cont. Ops) $0.91 -$0.17 $0.06 $0.18 -$0.00
Weighted Average Basic Share $40M $41.9M $42.5M $38.3M $38.9M
Weighted Average Diluted Share $40M $41.9M $42.5M $38.4M $38.9M
 
EBITDA $44.3M -$433K $10.8M $12.3M $1.9M
EBIT $38.7M -$7M $3.9M $5.1M -$4.9M
 
Revenue (Reported) $23.4M $34.5M $71.6M $76.9M $63.2M
Operating Income (Reported) -$1.2M -$8.8M $3.3M $4.8M -$3.8M
Operating Income (Adjusted) $38.7M -$7M $3.9M $5.1M -$4.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $144.7M $116.9M $217M $307.9M $282M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $101M $134M $205.1M $258M $247.8M
Gross Profit $43.7M -$17M $11.9M $49.9M $34.2M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $23.6M $26M $29.5M $37.4M $39M
Other Inc / (Exp) $33.2M -$18.8M $659K -$1.2M -$2M
Operating Expenses $25.5M $28.1M $31.6M $39.8M $41.7M
Operating Income $18.2M -$45.1M -$19.7M $10.1M -$7.5M
 
Net Interest Expenses $2.3M $2M $1.7M $1.3M $1.6M
EBT. Incl. Unusual Items $49.1M -$66M -$20.7M $7.6M -$11.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $5.9M -$24.7M -$5.2M -$4.5M -$5.5M
Net Income to Company $43.2M -$41.3M -$15.6M $12.1M -$5.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $43.2M -$41.3M -$15.6M $12.1M -$5.5M
 
Basic EPS (Cont. Ops) $1.09 -$0.98 -$0.37 $0.32 -$0.14
Diluted EPS (Cont. Ops) $1.09 -$0.98 -$0.37 $0.32 -$0.14
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $75.3M -$38.2M $8M $36.6M $19.5M
EBIT $51.4M -$64M -$19M $8.9M -$9.5M
 
Revenue (Reported) $144.7M $116.9M $217M $307.9M $282M
Operating Income (Reported) $18.2M -$45.1M -$19.7M $10.1M -$7.5M
Operating Income (Adjusted) $51.4M -$64M -$19M $8.9M -$9.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $97M $91.6M $181.9M $234M $220M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $71.2M $101M $163.5M $195.3M $188.6M
Gross Profit $25.8M -$9.4M $18.4M $38.7M $31.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $17.5M $18M $22M $28.6M $28.9M
Other Inc / (Exp) $41.1M -$14.1M $898K -$1.4M -$2.2M
Operating Expenses $18.9M $19.5M $23.7M $30.5M $30.9M
Operating Income $6.9M -$28.9M -$5.3M $8.2M $469K
 
Net Interest Expenses $1.6M $1.5M $1.2M $940K $1.2M
EBT. Incl. Unusual Items $46.4M -$44.6M -$5.6M $5.9M -$2.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $5.6M -$6.1M -$2.3M -$3.6M -$2.2M
Net Income to Company $40.8M -$38.4M -$3.3M $9.4M -$744K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $40.8M -$38.4M -$3.3M $9.4M -$744K
 
Basic EPS (Cont. Ops) $1.03 -$0.91 -$0.08 $0.26 -$0.02
Diluted EPS (Cont. Ops) $1.03 -$0.91 -$0.08 $0.26 -$0.02
Weighted Average Basic Share $119.7M $125.2M $126.8M $117.5M $116.2M
Weighted Average Diluted Share $119.7M $125.2M $126.8M $117.7M $116.2M
 
EBITDA $64.7M -$23.5M $16.1M $27.8M $20M
EBIT $48M -$43M -$4.4M $6.8M -$1.7M
 
Revenue (Reported) $97M $91.6M $181.9M $234M $220M
Operating Income (Reported) $6.9M -$28.9M -$5.3M $8.2M $469K
Operating Income (Adjusted) $48M -$43M -$4.4M $6.8M -$1.7M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $2.6M $11.7M $25.6M $5.5M $6.1M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $58.9M $69.7M $17.5M $35.7M $23.2M
Inventory $21.4M $19.1M $15M $20.2M $26.8M
Prepaid Expenses -- $11M $9.1M $3.9M $2.4M
Other Current Assets $4.4M -- -- $188K --
Total Current Assets $92.2M $112.1M $73.9M $68.1M $61.9M
 
Property Plant And Equipment $258.6M $306.8M $292.3M $284.9M $278.4M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $9M $8.3M $7.5M $6.7M $5.9M
Other Long-Term Assets $3.5M $563K $402K $303K $163K
Total Assets $363.4M $427.7M $374M $360M $346.3M
 
Accounts Payable $4M $3.3M $8.5M $14.4M $16M
Accrued Expenses $5.1M $9.1M $9.3M $10.4M $6.9M
Current Portion Of Long-Term Debt $6.1M $6.8M $7M $5.8M $7.5M
Current Portion Of Capital Lease Obligations $13.2M $7.2M $9.1M $11.3M $10.8M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $40M $37.3M $48.6M $51.9M $54.5M
 
Long-Term Debt $27.8M $22.1M $15.1M $9.3M $2.9M
Capital Leases -- -- -- -- --
Total Liabilities $117.8M $138.9M $132.9M $116.5M $104M
 
Common Stock $40K $42K $42K $43K $39K
Other Common Equity Adj -$41K $423K $574K $227K -$35K
Common Equity $245.6M $288.8M $241.2M $243.5M $242.3M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $245.6M $288.8M $241.2M $243.5M $242.3M
 
Total Liabilities and Equity $363.4M $427.7M $374M $360M $346.3M
Cash and Short Terms $2.6M $11.7M $25.6M $5.5M $6.1M
Total Debt $33.8M $28.9M $22.1M $15.2M $18.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $11M $36.7M $10.4M $9.3M $7.2M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $66M $15.6M $32.9M $24M $24.2M
Inventory $23.6M $15.4M $20.6M $26M $27.8M
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.5M $14M $7.4M $712K $2.8M
Total Current Assets $111.4M $82.7M $72.6M $60.2M $64.7M
 
Property Plant And Equipment $313.3M $292.6M $295.6M $280.1M $264.6M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $3.4M $446K $315K $185K $1.2M
Total Assets $436.6M $383.4M $375.4M $346.5M $335.8M
 
Accounts Payable $3.3M $4.8M $11.6M $10.4M $10.9M
Accrued Expenses $5.1M $7.3M $10.9M $10.7M $7.2M
Current Portion Of Long-Term Debt $6.3M $7.2M $6.3M $5.5M $1M
Current Portion Of Capital Lease Obligations $8.9M $7.5M $10.8M $11.3M $9.7M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $41M $40M $54.9M $44.7M $37.8M
 
Long-Term Debt $23.5M $16.7M $16.3M $6.3M $9.5M
Capital Leases -- -- -- -- --
Total Liabilities $145.9M $131.1M $135.8M $100.4M $92.3M
 
Common Stock $42K $42K $42K $38K $39K
Other Common Equity Adj $276K $353K $250K -$27K -$50K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $290.7M $252.2M $239.6M $246.1M $243.6M
 
Total Liabilities and Equity $436.6M $383.4M $375.4M $346.5M $335.8M
Cash and Short Terms $11M $36.7M $10.4M $9.3M $7.2M
Total Debt $29.8M $23.9M $22.5M $11.8M $13M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $31.6M $38M -$50.7M -$703K $4.6M
Depreciation & Amoritzation $27.8M $22.9M $26.1M $27.3M $28.3M
Stock-Based Compensation $3M $3.9M $3.2M $3.2M $3.5M
Change in Accounts Receivable -$38M -$6.1M $30.9M -$16.5M $10M
Change in Inventories -$1M $4.7M $1.9M -$5.2M -$6.6M
Cash From Operations $44.6M $25.5M $32.4M $5.4M $31M
 
Capital Expenditures $25.5M $8.6M $11.2M $12.7M $23M
Cash Acquisitions -- -- -- -$6.5M --
Cash From Investing -$25.4M -$8.6M -$11.1M -$18.2M -$22.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $84M $7M -- $10M $23M
Long-Term Debt Repaid -$97.7M -$13.4M -$6.9M -$17.4M -$25.8M
Repurchase of Common Stock -$140K -$1.2M -$401K -$540K -$4.8M
Other Financing Activities -$4.3M -$330K -$180K -- --
Cash From Financing -$18M -$7.9M -$7.4M -$7.3M -$7.5M
 
Beginning Cash (CF) $1.5M $2.6M $11.7M $25.6M $5.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.2M $9.1M $13.9M -$20.1M $562K
Ending Cash (CF) $2.6M $11.7M $25.6M $5.5M $6.1M
 
Levered Free Cash Flow $19.1M $16.9M $21.2M -$7.3M $8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $36.3M -$7.3M $2.7M $6.7M -$98K
Depreciation & Amoritzation $5.6M $6.5M $6.9M $7.2M $6.8M
Stock-Based Compensation $945K $889K $815K $865K $872K
Change in Accounts Receivable -$19.2M -$5M $2.8M $6.1M $3.7M
Change in Inventories -$822K $556K -$3.7M -$3M -$2.8M
Cash From Operations -$3.6M $1.1M $10.8M $12.5M $5.8M
 
Capital Expenditures $1M $1.9M $4.4M $6.9M $2.1M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$970K -$1.9M -$3.4M -$6.8M -$2.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $3M -- $2.6M
Long-Term Debt Repaid -$1.1M -$1.8M -$1.9M -$1.7M -$4.7M
Repurchase of Common Stock -$1K -$6K -$210K -$150K -$153K
Other Financing Activities -- -- -- -- -$626K
Cash From Financing -$1.1M -$1.8M $896K -$1.8M -$2.8M
 
Beginning Cash (CF) $16.6M $39.3M $2.1M $5.5M $6.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$5.6M -$2.6M $8.3M $3.8M $958K
Ending Cash (CF) $11M $36.7M $10.4M $9.3M $7.2M
 
Levered Free Cash Flow -$4.6M -$869K $6.4M $5.6M $3.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $43.2M -$41.3M -$15.6M $12.1M -$5.5M
Depreciation & Amoritzation $24M $25.8M $27.1M $27.7M $29M
Stock-Based Compensation $3.7M $3.1M $3.5M $3.2M $3.4M
Change in Accounts Receivable -$16.4M $39.1M -$17.6M $10M -$2.7M
Change in Inventories -$3.4M $8.2M -$7.4M -$5.3M -$1.9M
Cash From Operations $26.5M $40.9M -$5.3M $39.2M $14.2M
 
Capital Expenditures $13.5M $8.2M $13.8M $19.3M $12M
Cash Acquisitions -- -- -$6.5M -- --
Cash From Investing -$13.3M -$8.1M -$19.3M -$19.1M -$12M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $47M -- $6M $19M $34.7M
Long-Term Debt Repaid -$48.5M -$6.6M -$7.2M -$36.2M -$36.2M
Repurchase of Common Stock -$1M -$403K -$558K -$4.7M -$500K
Other Financing Activities -$1.9M -$180K -- -- --
Cash From Financing -$4.3M -$7.1M -$1.7M -$21.2M -$4.3M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $8.9M $25.7M -$26.3M -$1.1M -$2.1M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $13.1M $32.7M -$19.1M $19.9M $2.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $40.8M -$38.4M -$3.3M $9.4M -$744K
Depreciation & Amoritzation $16.7M $19.5M $20.5M $21M $21.7M
Stock-Based Compensation $2.9M $2.2M $2.5M $2.5M $2.4M
Change in Accounts Receivable -$11.5M $33.7M -$14.8M $11.6M -$1.1M
Change in Inventories $306K $3.8M -$5.6M -$5.8M -$1M
Cash From Operations $22.2M $37.5M -$168K $33.7M $16.8M
 
Capital Expenditures $7.4M $7M $9.5M $16.1M $5.1M
Cash Acquisitions -- -- -$6.5M -- --
Cash From Investing -$7.4M -$6.9M -$15.1M -$16M -$5.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $7M -- $6M $15M $26.7M
Long-Term Debt Repaid -$12.1M -$5.3M -$5.6M -$24.3M -$34.7M
Repurchase of Common Stock -$1M -$294K -$451K -$4.6M -$375K
Other Financing Activities -$330K -$180K -- -- -$2.4M
Cash From Financing -$6.5M -$5.7M $39K -$13.8M -$10.6M
 
Beginning Cash (CF) $30.8M $62.4M $32.4M $18.6M $16.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $8.4M $25M -$15.2M $3.8M $1.1M
Ending Cash (CF) $39.2M $87.4M $17.2M $22.4M $18.1M
 
Levered Free Cash Flow $14.8M $30.6M -$9.7M $17.5M $11.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock